Status:
COMPLETED
Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real Practice
Lead Sponsor:
Handok Inc.
Conditions:
Asthma
Eligibility:
All Genders
6-18 years
Brief Summary
This is a prospective, non-comparative, open, observational study.
Eligibility Criteria
Inclusion
- Children who is prescribed with ciclesonide for asthma
Exclusion
- Subjects with contraindications to ciclesonide use
- Subjects with clinically relevant concomitant disease that could compromise the patient's safety should not be included in this study.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT01438255
Start Date
July 1 2010
Last Update
August 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Handok Pharmaceuticals
Seoul, Seoul, South Korea